These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11422015)

  • 21. D-xylose absorption in non-chronic diarrhea AIDS patients with the wasting syndrome.
    Luangjaru S; Ruxrungtham K; Wisedopas N; Mahachai V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S477-83. PubMed ID: 12930028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea.
    Lambl BB; Federman M; Pleskow D; Wanke CA
    AIDS; 1996 Jun; 10(7):739-44. PubMed ID: 8805864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.
    Acosta EP; Brundage RC; King JR; Sánchez PJ; Sood S; Agrawal V; Homans J; Jacobs RF; Lang D; Romero JR; Griffin J; Cloud G; Whitley R; Kimberlin DW;
    Clin Pharmacol Ther; 2007 Jun; 81(6):867-72. PubMed ID: 17392728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study.
    Pescovitz MD; Brook B; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Clin Transplant; 1997 Dec; 11(6):613-7. PubMed ID: 9408695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in small intestinal structure and function in HIV-infected patients with chronic diarrhoea.
    Oktedalen O; Skar V; Dahl E; Serck-Hanssen A
    Scand J Infect Dis; 1998; 30(5):459-63. PubMed ID: 10066044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zidovudine absorption and small intestinal function in HIV seropositive patients.
    Macnab KA; Gill MJ; Sutherland LR; Murphy A; Brant R
    J Antimicrob Chemother; 1996 Apr; 37(4):825-9. PubMed ID: 8722550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients.
    Wiltshire H; Hirankarn S; Farrell C; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N;
    Clin Pharmacokinet; 2005; 44(5):495-507. PubMed ID: 15871635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steady-state relative bioavailability of three oral ganciclovir dosage regimens delivering 6,000 mg/day in patients with human immunodeficiency virus.
    Jung D; Griffy K; Wong R; Colburn W; Hulse J
    J Clin Pharmacol; 1998 Nov; 38(11):1021-4. PubMed ID: 9824783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage.
    Kelly P; Davies SE; Mandanda B; Veitch A; McPhail G; Zulu I; Drobniewski F; Fuchs D; Summerbell C; Luo NP; Pobee JO; Farthing MJ
    Gut; 1997 Dec; 41(6):811-6. PubMed ID: 9462215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Pharmacokinetics of Ganciclovir in Critically Ill Patients.
    Krens SD; Hodiamont CJ; Juffermans NP; Mathôt RAA; van Hest RM
    Ther Drug Monit; 2020 Apr; 42(2):295-301. PubMed ID: 31425489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
    N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body composition and nutritional parameters in HIV and AIDS patients.
    Salomon J; de Truchis P; Melchior JC
    Clin Chem Lab Med; 2002 Dec; 40(12):1329-33. PubMed ID: 12553439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease.
    Kapembwa MS; Fleming SC; Orr M; Wells C; Bland M; Back D; Griffin GE
    AIDS; 1996 Nov; 10(13):1509-14. PubMed ID: 8931785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute bioavailability and dose proportionality of oral ganciclovir after ascending multiple doses in human immunodeficiency virus (HIV)-positive patients.
    Jung D; Griffy K; Wong R; Colburn W; Hulse J
    J Clin Pharmacol; 1998 Dec; 38(12):1122-8. PubMed ID: 11301564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional abnormalities in HIV/AIDS.
    Dunn JM
    HIV Hotline; 1998 May; 8(2):11-2. PubMed ID: 11365362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.
    Kappelhoff BS; Huitema AD; Yalvaç Z; Prins JM; Mulder JW; Meenhorst PL; Beijnen JH
    Clin Pharmacokinet; 2005; 44(8):849-61. PubMed ID: 16029069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.